Literature DB >> 25124623

Insulin promotes proliferation and migration of breast cancer cells through the extracellular regulated kinase pathway.

Feng Pan1, Li-Quan Hong.   

Abstract

The present study was undertaken to determine the roles of insulin in the growth of transplanted breast cancer in nude mice, and the proliferation and migration of MCF-7 human breast cancer cells and assess its influence on downstream signaling pathways. In a xenograft mouse model with injection of MCF-7 human breast cancer cells, tumor size was measured every other day. The insulin level and insulin receptor (IR) were increased in the breast cancer patient tissues. Insulin injected subcutaneously around the tumor site in mice caused increase in the size and weight of tumor masses, and promoted proliferation and migration of MCF-7 cells. The effects of insulin on the increase in the proliferation and migration of MCF-7 human breast cancer cells were abolished by pretreatment with the extracellular regulated kinase (ERK) inhibitor PD98059. Insulin increased the phosphorylation of ERK in the MCF-7 cells. These results indicate that insulin promotes the growth of breast cancer in nude mice, and increases the proliferation and migration of MCF-7 human breast cancer cells via the ERK pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25124623     DOI: 10.7314/apjcp.2014.15.15.6349

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  12 in total

1.  ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins.

Authors:  Lixia Bai; Rui Mao; Jintao Wang; Ling Ding; Shiwen Jiang; Chenfei Gao; Huijie Kang; Xiao Chen; Xuesong Sun; Juan Xu
Journal:  Med Oncol       Date:  2015-02-03       Impact factor: 3.064

2.  Role of EHD2 in migration and invasion of human breast cancer cells.

Authors:  Xiaojing Yang; Hanru Ren; Li Yao; Xueyu Chen; Aina He
Journal:  Tumour Biol       Date:  2015-01-05

Review 3.  Insulin Receptor Isoforms in Physiology and Disease: An Updated View.

Authors:  Antonino Belfiore; Roberta Malaguarnera; Veronica Vella; Michael C Lawrence; Laura Sciacca; Francesco Frasca; Andrea Morrione; Riccardo Vigneri
Journal:  Endocr Rev       Date:  2017-10-01       Impact factor: 19.871

4.  A constriction channel analysis of astrocytoma stiffness and disease progression.

Authors:  P M Graybill; R K Bollineni; Z Sheng; R V Davalos; R Mirzaeifar
Journal:  Biomicrofluidics       Date:  2021-03-16       Impact factor: 2.800

Review 5.  Hyperinsulinemia in Obesity, Inflammation, and Cancer.

Authors:  Anni M Y Zhang; Elizabeth A Wellberg; Janel L Kopp; James D Johnson
Journal:  Diabetes Metab J       Date:  2021-03-29       Impact factor: 5.893

Review 6.  Insulin and cancer: a tangled web.

Authors:  Brooks P Leitner; Stephan Siebel; Ngozi D Akingbesote; Xinyi Zhang; Rachel J Perry
Journal:  Biochem J       Date:  2022-03-18       Impact factor: 3.766

7.  Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.

Authors:  Veronica Vella; Roberta Malaguarnera; Maria Luisa Nicolosi; Chiara Palladino; Cristina Spoleti; Michele Massimino; Paolo Vigneri; Michele Purrello; Marco Ragusa; Andrea Morrione; Antonino Belfiore
Journal:  Oncotarget       Date:  2017-06-27

8.  miR-29a regulated ER-positive breast cancer cell growth and invasion and is involved in the insulin signaling pathway.

Authors:  Zhi-Hua Li; Qiu-Yun Xiong; Liang Xu; Peng Duan; Qianwen Ou Yang; Ping Zhou; Jian-Hong Tu
Journal:  Oncotarget       Date:  2017-05-16

9.  Mesenchymal stem cell-conditioned medium promotes MDA-MB-231 cell migration and inhibits A549 cell migration by regulating insulin receptor and human epidermal growth factor receptor 3 phosphorylation.

Authors:  Pengfei Li; Hongwei Zhou; Guohu Di; Jin Liu; Yang Liu; Zhihong Wang; Yinxuan Sun; Haifeng Duan; Junzhong Sun
Journal:  Oncol Lett       Date:  2017-01-25       Impact factor: 2.967

10.  Revisiting the IGF-1R as a breast cancer target.

Authors:  Roudy Chiminch Ekyalongo; Douglas Yee
Journal:  NPJ Precis Oncol       Date:  2017-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.